Studies related to HbA1c and Citrullus colocynthis

The Clinical Investigation Of Citrullus Colocynthis (L.) Schrad Fruit In Treatment Of Type II Diabetic Patients: A Randomized, Double Blind, Placebo-controlled Clinical Trial

Effect Decrease
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 50
Sex Both Genders
Age Range 45-64
Body Types Average
Notes for this study:
Supplementation of 100mg of the dried fruits of Citrullus colocynthis thrice daily (300mg each day) for two months in adults with type II diabetes was able to reduce blood glucose and HbA1c without any influence on the lipid profile; this study is limited due to the experimental group having a higher baseline glucose and HbA1c relative to placebo at baseline.